The tyrosine phosphatase SHP-1 dampens murine Th17 development

Blood

Volumn 119, Issue 19, 2012, Pages 4419-4429

  Mauldin, Ileana S ^a   Tung, Kenneth S ^a   Lorenz, Ulrike M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EX VIVO STUDY; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TH17 CELL; TRANSGENICS;

EID: 84861088408     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-377069     Document Type: Article

References (44)

1. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149-162.
2. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27: 485-517.
3. Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 2009;126(2):177-185.
4. Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol. 2011;23(5):613-619.
5. Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485-498.
6. Atarashi K, Tanoue T, Honda K. Induction of lamina propria Th17 cells by intestinal commensal bacteria. Vaccine. 2010;28(50):8036-8038.
7. Niess JH, Leithauser F, Adler G, Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol. 2008;180(1):559-568.
8. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol. 2007;19(6):409-417. (Pubitemid 351274050)
9. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity. 2008;28(4): 445-453. (Pubitemid 351467042)
10. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006; 24(6):677-688. (Pubitemid 43867371)
11. Hemdan NY, Birkenmeier G, Wichmann G, et al. Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev. 2010;9(11):785-792.
12. Chen Z, O'Shea JJ. Th17 cells: a new fate for differentiating helper T cells. Immunol Res. 2008; 41(2):87-102.
13. Bronte V. Th17 and cancer: friends or foes? Blood. 2008;112(2):214.
14. Muranski P, Boni A, Antony PA, et al. Tumorspecific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112(2):362-373.
15. Prabhala RH, Pelluru D, Fulciniti M, et al. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood. 2010;115(26): 5385-5392.
16. Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol. 2010; 10(4):248-256.
17. Zhou L, Littman DR. Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol. 2009;21(2):146-152.
18. Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28(1):29-39.
19. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15: 797-819. (Pubitemid 27169299)
20. Yu Q, Sharma A, Ghosh A, Sen JM. T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J Immunol. 2011; 186(7):3946-3952.
21. Lorenz U. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev. 2009;228(1):342-359.
22. Carter JD, Neel BG, Lorenz U. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int Immunol. 1999;11(12):1999-2014.
23. Iype T, Sankarshanan M, Mauldin IS, Mullins DW, Lorenz U. The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells. J Immunol. 2010;185(10): 6115-6127.
24. Pathak MK, Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol. 2001;167(6):3391-3397. (Pubitemid 32852583)
25. Naing A. NCT00629200: sodium stibogluconate with interferon alpha-2b for patients with advanced malignancies [NCI clinical trial]. Houston, TX: MD Anderson Cancer Center. 2006; http://clinical trials.gov/ct2/show/NCT00629200.
26. Borden E. NCT00498979: sodium stibogluconate and interferon alfa-2b followed by cisplatin, vinblastine, and temozolomide in treating patients with advanced melanoma or other cancer [NCI clinical trial]. Cleveland, OH: Case Comprehensive Cancer Center. 2007; http://clinicaltrials.gov/ct2/show/ NCT00498979.
27. Borden E. NCT00311558: sodium stibogluconate and interferon in treating patients with advanced solid tumors, lymphoma, or myeloma [NCI clinical trial]. Cleveland, OH: Case Comprehensive Cancer Center. 2006; http://clinicaltrials. gov/ct2/show/NCT0031158.
28. Lee PP, Fitzpatrick DR, Beard C, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001;15(5):763-774. (Pubitemid 34008504)
29. Zhang L, Camerini V, Bender TP, Ravichandran KS. A nonredundant role for the adapter protein Shc in thymic T cell development. Nat Immunol. 2002; 3(8):749-755.
30. Carter JD, Calabrese GM, Naganuma M, Lorenz U. Deficiency of the Src homology region 2 domaincontaining phosphatase 1 (SHP-1) causes enrichment of CD4-CD25- regulatory T cells. J Immunol. 2005;174(11):6627-6638. (Pubitemid 40705623)
31. Durant L, Watford WT, Ramos HL, et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity. 2010;32(5):605-615.
32. Uhlig HH, Coombes J, Mottet C, et al. Characterization of Foxp3-CD4-CD25-and IL-10-secreting CD4-CD25-T cells during cure of colitis. J Immunol. 2006;177(9):5852-5860.
33. Timms JF, Carlberg K, Gu H, et al. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol Cell Biol. 1998; 18(7):3838-3850. (Pubitemid 28287907)
34. Wei L, Laurence A, Elias KM, O'Shea JJ. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem. 2007;282(48):34605-34610. (Pubitemid 350232469)
35. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448(7152):484-487. (Pubitemid 47123515)
36. Dang EV, Barbi J, Yang HY, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146(5):772-784.
37. Kryczek I, Zhao E, Liu Y, et al. Human TH17 cells are long-lived effector memory cells. Sci Transl Med. 2011;3(104):104ra100.
38. Peters A, Lee Y, Kuchroo VK. The many faces of Th17 cells. Curr Opin Immunol. 2011;23(6):702-706.
39. Ghoreschi K, Laurence A, Yang XP, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature. 2010;467(7318): 967-971.
40. El-Behi M, Ciric B, Dai H, et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GMCSF. Nat Immunol. 2011;12(6):568-575.
41. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8(12):1390-1397. (Pubitemid 350138974)
42. Shi G VB, Lovaas J, Tang C, Aziz M, Gery I. Pathogenic or non-pathogenic subpopulations of Th17 cells are generated by stimulation of naïve CD4 cells via antigen/APC or anti-CD3/CD28 antibodies. J Immunol Meeting Abstract Suppl. 2010;184:135.110.
43. Shi G, Ramaswamy M, Vistica BP, et al. Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation- induced cell death. J Immunol. 2009; 183(11):7547-7556.
44. O'Connor RA, Prendergast CT, Sabatos CA, et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol. 2008;181(6):3750-3754.